These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1127 related articles for article (PubMed ID: 28858731)

  • 1. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.
    Yu PF; Kang AR; Jing LJ; Wang YM
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):993-1002. PubMed ID: 29509247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y; Dong ZY; Wang JY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.
    Cheng Y
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of lncRNA FEZF1-AS1 promotes progression of non-small cell lung cancer
    Li F; Xiang J; Liu J; Wang X; Jiang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):841-850. PubMed ID: 38862441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC.
    Gong W; Cao Y; Wang Y; Yang L; Su W; Qiu F; Datta S; Rao B; Xian J; Lin M; Feng Y; Zhang X; Zhou Y; Gao X; Lu J
    Pathol Res Pract; 2018 Jun; 214(6):857-861. PubMed ID: 29709443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
    Wu Y; Lyu H; Liu H; Shi X; Song Y; Liu B
    Sci Rep; 2016 Aug; 6():31093. PubMed ID: 27489122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
    Zhao X; Cheng Z; Wang J
    Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.
    Yao J; Yang Z; Yang J; Wang ZG; Zhang ZY
    Aging (Albany NY); 2021 May; 13(10):13726-13738. PubMed ID: 34023817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
    Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
    Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
    Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.
    Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y
    Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
    J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.